ESG investing: 3 UK shares I’d consider

Looking for shares to buy now from an ESG investing perspective, Christopher Ruane weighs the investment case for three UK stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ESG investing has become more popular as investors consider the environmental, social, and governance aspects of their holdings. The idea of ESG investing may sound appealing. But in practice there is no agreed standard of what constitutes an ESG share.

Here are three shares I think have at least some ESG credentials. I consider whether I would add them to my portfolio – but only one attracts me right now.

Access to medicine leader

Well-known pharma giant GlaxoSmithKline (LSE: GSK) is often prominent on lists ranking shares by their ESG credentials. That is because of the company’s focus on broadening access to medicine. The company came top out of 20 pharma companies assessed in this year’s Access to Medicine Index. GSK’s pipeline includes drugs targeting priority diseases prevalent in poorer countries.

That may give GSK some credibility when it comes to ESG investing. But I feel the investment case for the company is more mixed. The relative weakness of its pipeline has worried analysts in recent years. The dividend of 5.6% is attractive for a FTSE 100 stalwart. But the company has indicated that it may effectively reduce the dividend after the imminent spin-off of its consumer division.

Despite improving steadily since the start of March, the GSK share price is still down 14% over the past year. That reflects investor nervousness about the strategic listlessness of the company and its pipeline. The spin-off could help bring more focus – but that isn’t guaranteed. I’m tempted by the yield, but for now am sitting out GSK to see how the spin-off goes.

ESG investing in recycling

Shares in recycling service providers are an obvious candidate for ESG investing. Should I consider buying shares in Augean (LSE: AUG), which specialises in hazardous waste management? From landfill sites to decommissioned oil rigs, Augean is involved in activities including waste treatment and recycling.

There has been talk of a possible bid for Augean. The deadline for a firm bid expired last week but has now been extended to next month. The Augean share price is up 59% in the past year. Augean shares now trade on a price-to-earnings ratio of almost 20.

I think the company has growth potential due to its specialist expertise at a time of heightening environmental standards. But after an increase following the news of a possible bid, I wouldn’t add the shares to my portfolio right now. If a bid doesn’t materialise, the shares risk returning to where they were before bid speculation emerged.

Closed loop recycling

Another company involved in recycling is paper and packaging firm D S Smith (LSE: SMDS). From an ESG investing perspective, its closed loop approach to recycling offers environmental benefits.

I also like D S Smith’s business performance and strategic focus. Last year, revenue and post-tax profits both fell due to the pandemic. But demand for packaging has surged due to an increase in online shopping. With its well-established operations in Europe and North America, D S Smith should benefit from that. The demand surge also poses a risk, though, as material prices have moved sharply up – something the company flagged in its results last week. That could hurt profit margins.

But with its proven ability to profit from paper and packaging, I would consider buying D S Smith for my portfolio.

Christopher Ruane has no shares in any company mentioned. The Motley Fool UK has recommended DS Smith and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up as a woman counts out modern British banknotes.
Investing Articles

How to target a 14%+ dividend yield by investing £10,000

There are many strategies for the average investor targeting a 14% dividend yield or higher. Our Foolish author explores one…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Up 6%, can this ‘gritty’ stock continue outperforming the rest of the FTSE 250?

ITV's share price is soaring as investors react to a resilient performance in 2025. The question is, can the FTSE…

Read more »

Investing Articles

How much income could £20k in a Stocks and Shares ISA give you today?

As the clock ticks on this year's Stocks and Shares ISA allowance, Harvey Jones looks at how investors could use…

Read more »

Investing Articles

What next for the Endeavour Mining share price after a record-breaking set of results?

Since March 2025, Endeavour Mining’s share price has risen 175%. Do the gold miner’s latest results provide any clues as…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

How are Rolls-Royce shares looking in March 2026?

March promises to be an interesting time for Rolls-Royce shares, but should investors be worried or calm about developments?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

3 these stocks are smashing BAE Systems shares – are they worth considering today? 

Harvey Jones looks at the impact of current events on BAE Systems shares this week, and highlights some FTSE 100…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

At a forward P/E of 17, is Nvidia stock now a screaming buy?

Stephen Wright outlines why Nvidia stock could be better value now than it has been in a long time, despite…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

I asked ChatGPT to name the most undervalued share on the UK stock market. Here’s what it said…

Always on the lookout for value shares to add to his portfolio, James Beard turned to a well-known artificial intelligence…

Read more »